How to Submit to NEJM: Step-by-Step Guide (2026)

NEJM has an impact factor of 78.5 , the highest of any clinical journal. It also rejects over 90% of submitted manuscripts at the desk, before a single external reviewer reads them.

That rejection rate is the most important number for authors to understand before submitting. The desk decision is the bottleneck, and clearing it requires a clear-eyed assessment of whether your paper meets a very specific bar.

What NEJM Publishes (and What It Doesn't)

NEJM's scope is clinical medicine. The question editors ask at the desk is simple: does this finding change how physicians care for patients?

Papers that clear the desk at NEJM tend to share these characteristics:

• Large, well-designed randomized trials with definitive results on clinically important endpoints (mortality, major cardiovascular events, disease progression)
• Practice-changing findings , not just statistically significant, but large enough in magnitude to affect real treatment decisions
• Broad patient population , findings that affect large numbers of patients, not rare disease subgroups
• Clear clinical question , studies that answer a question physicians are actually asking in practice

What NEJM doesn't publish:

• Basic science and translational research (those go to specialty journals)
• Single-center retrospective studies, regardless of sample size
• Exploratory analyses and secondary endpoints from trials designed to answer a different primary question
• Quality improvement studies and educational research
• Pure methodology papers without clinical findings

NEJM Article Types

NEJM publishes several distinct article types with different requirements:

Original Articles: Randomized trials and major observational studies. Main text 3,400 words, abstract 250 words, 4 tables/figures maximum, 50 references maximum.

Brief Reports: Shorter clinical findings, including some trial results. Main text 1,800 words, abstract 150 words, 2 tables/figures.

Case Records (MGH Case Records): MGH's weekly clinicopathological conference. These are solicited by NEJM, not submitted through the standard portal.

Clinical Problem-Solving: Step-by-step case presentations with expert reasoning. About 1,800 words. Competitive , requires a genuinely instructive case.

Perspective Articles: Opinion pieces on important clinical and policy issues. About 1,200 words. Usually solicited, but unsolicited pieces are considered.

Review Articles: Almost entirely solicited. Don't submit an unsolicited review to NEJM.

The Cover Letter

NEJM's cover letter must do three things in under one page:

1. State the primary finding in one sentence with a specific number , the hazard ratio, the absolute risk reduction, the primary endpoint result
2. Explain why this changes clinical practice , which patients, which decision, at what scale
3. Confirm that the paper hasn't been published or submitted elsewhere

What works: "Our trial of [treatment A vs. B] in [N] patients with [condition] showed that [treatment A] reduced [primary endpoint] by [X]% (HR 0.72; 95% CI 0.61-0.85; p<0.001). These findings support a change in first-line treatment for [patient group], which affects approximately [X] million patients annually in the US."

What doesn't work: "We are pleased to submit our randomized controlled trial, which we believe will be of great interest to NEJM readers." This adds no information and signals the authors haven't thought carefully about why this specific paper belongs in NEJM specifically.

Formatting Before You Submit

NEJM's formatting requirements for original articles:

• Main text: 3,400 words maximum (excluding abstract, references, tables, figure legends)
• Abstract: 250 words, structured (Background, Methods, Results, Conclusions)
• Tables and figures: 4 combined maximum
• References: 50 maximum, in the order they appear in text
• Clinical trial registration: required, in a WHO-approved registry, before patient enrollment began
• CONSORT flow diagram: required for all randomized trials
• Data sharing statement: required; NEJM has specific data-sharing policies depending on funder requirements

Use the NEJM author instructions page for the complete list , these details change, and submission system validation will reject papers that don't meet length limits.

Desk Rejection: What Happens and Why

NEJM's senior editors make desk decisions based on scope, significance, and design. Papers are rejected at the desk when:

• The finding doesn't clearly change clinical practice (methodologically sound but incremental)
• The study design has a fundamental limitation that prevents definitive conclusions
• The scope is too narrow (a finding primarily relevant to one subspecialty, not internal medicine broadly)
• The paper is a post-hoc analysis of a trial designed to answer a different primary question
• The paper has already been substantially published (preprint alone doesn't disqualify; published companion papers might)

The 90%+ desk rejection rate means that submitting a paper to NEJM that isn't clearly in the top tier of your field's clinical literature is unlikely to succeed. Be honest with yourself about whether your findings genuinely change practice before submitting.

If You Clear the Desk: Peer Review at NEJM

Papers that proceed to peer review go to 2-4 experts , typically clinicians, methodologists, and statisticians. NEJM's peer review is thorough and detailed. Expect:

• Requests for additional sensitivity analyses and subgroup breakdowns
• Scrutiny of statistical methods and endpoint definitions
• Detailed questions about protocol deviations and their potential effect on results
• Requests for clearer framing of clinical implications

Revision timelines: NEJM expects responses within 3 months for major revisions and 6 weeks for minor revisions. Extensions are available if requested in advance.

Next Options After an NEJM Rejection

Most NEJM rejections don't mean the paper is flawed , they mean the paper isn't at the NEJM significance level for their current issue mix. The appropriate next target depends on the paper:

• The Lancet: if the findings have global relevance or strong international trial data
• JAMA: for US clinical medicine with clear practice implications
• BMJ: for health policy, primary care, or global health angles
• Annals of Internal Medicine: for internal medicine clinical research that doesn't clear the NEJM/JAMA bar
• Field-specific journals: for findings primarily relevant to one subspecialty

Common Mistakes to Avoid

Most authors lose time in this topic for one reason: they optimize the wrong variable first. They spend hours polishing language while leaving structural issues unresolved. Editors and reviewers evaluate structure before style.

In practice, the recurring mistakes are predictable:

1. Using generic claims instead of specifics. Replace vague statements with concrete numbers, study details, and explicit scope boundaries.
2. Ignoring fit and audience. A strong manuscript sent to the wrong journal or framed for the wrong reader still fails quickly.
3. Treating revision as proofreading. Revision is where argument quality, methodological clarity, and limitation handling should improve meaningfully.
4. Skipping process checks. Formatting, references, checklist compliance, and data statements look administrative, but they're part of editorial quality control.

A useful rule is to run one final pre-submission pass that checks only these operational risks: scope fit, claim strength, methods clarity, and policy compliance. That pass catches most avoidable rejection reasons before they become reviewer comments.

If you're deciding between two valid options, pick the one that improves clarity for an external reader who has no context besides your paper. Clearer framing beats denser writing almost every time.

NEJM's Statistical Review Process

NEJM has an in-house statistical review team that evaluates every paper that clears the desk. This is different from most journals, where statistical review depends entirely on whether the external reviewers happen to be statisticians.

What NEJM's statisticians look for:

• Is the primary endpoint pre-specified and consistent with the protocol?
• Are confidence intervals reported alongside p-values for all primary results?
• Are the subgroup analyses pre-specified or post-hoc, and are they powered appropriately?
• Is the method for handling missing data appropriate and clearly described?
• Are survival curves complete with numbers-at-risk tables?

Papers with statistical gaps don't get desk-rejected for statistical issues alone, but they receive statistical review comments during peer review. Addressing these proactively saves a round of revision.

The most common statistical revision request at NEJM: insufficient reporting of confidence intervals and effect sizes. P<0.05 alone is not acceptable. Report the HR (or RR, OR, MD) with its 95% CI for every primary and secondary endpoint.

The Rapid Response Letter

NEJM publishes Letters to the Editor in its Correspondence section. These are short (250-300 words) responses to recently published articles. For researchers who want to engage with NEJM without the full manuscript process, a well-argued letter on a relevant recently published trial is a legitimate pathway.

Letters that get published: those that raise a substantive methodological concern, provide new data that extends the original finding, or offer a clinical perspective that adds genuine value to the original paper.

Letters that don't get published: those that simply agree or disagree without adding new information, those that repeat points already made in the original paper's limitations section, and those that are primarily promotional.

The word limit is strict. State your point in the first sentence and don't use the 250 words to build background the editors already have.

The Bottom Line

NEJM is the right target for landmark clinical trials and major observational studies that definitively change medical practice at scale. The desk rejection rate is high because the scope is specific and the significance bar is demanding. A well-prepared paper that meets those criteria has a real shot , but a paper that doesn't clearly change clinical practice is unlikely to clear the desk regardless of how carefully it's formatted.

See also

• NEJM acceptance rate and what it takes to get in
• Lancet vs. NEJM: how to choose
• JAMA submission guide

• NEJM journal profile
• NEJM acceptance rate 2026

Sources

• NEJM author information (nejm.org/author-center)
• NEJM editorial policies (nejm.org/about-nejm)
• ICMJE recommendations (icmje.org)
• Pre-Submission Checklist